Zalicus zalicus.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination drug discovery technology to identify new combination product candidates in a number of disease areas, including immunoinflammatory disease, oncology, metabolic disease, neurodegenerative disease, and infectious disease.

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. CombinatoRx applies its proprietary combination dr...Show all

Company (Acquired)

Phone: 617-301-7000

Fax:

245 First Street
Third Floor
Cambridge, 02142
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zalicus $76.4M May 16, 2014
Inhibitex $209.8M Aug 12, 2005
Innoviva $257.7M Oct 5, 2004
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zalicus Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 16 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Heterocyclic inhibitors of the sodium channel Feb 27, 2014 Feb 19, 2019 Patent
Solid dispersion formulations and methods of use thereof Mar 07, 2012 Nov 26, 2013 Patent
Compositions and methods for treatment of filovirus-mediated diseases Feb 22, 2010 Jul 02, 2013 Patent
Solid dispersion formulations and methods of use thereof Jun 12, 2012 Apr 02, 2013 Patent
Methods, compositions, and kits for the treatment of ophthalmic disorders Nov 28, 2011 Sep 04, 2012 Patent
See all 9 patents